| Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open … M Assem, M Elsabaawy, M Abdelrashed, S Elemam, S Khodeer, ... Hepatology international 10, 377-385, 2016 | 73 | 2016 |
| Role of occult hepatitis B virus in chronic hepatitis C patients with flare of liver enzymes HS Selim, HA Abou-Donia, HA Taha, GI El Azab, AF Bakry European Journal of Internal Medicine 22 (2), 187-190, 2011 | 46 | 2011 |
| Evaluation of serum cystatin C as a marker of early renal impairment in patients with liver cirrhosis M Omar, W Abdel-Razek, G Abo-Raia, M Assem, G El-Azab International journal of hepatology 2015, 2015 | 40 | 2015 |
| Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized … M Assem, G El Azab, MA Rasheed, M Abdelfatah, M Shastery European Journal of Internal Medicine 21 (4), 310-314, 2010 | 40 | 2010 |
| Study of adiponectin in chronic liver disease and cholestasis TA Salman, N Allam, GI Azab, AA Shaarawy, MM Hassouna, ... Hepatology international 4, 767-774, 2010 | 38 | 2010 |
| Portal and splanchnic hemodynamics after partial splenic embolization in cirrhotic patients with hypersplenism AZ Helaly, MS Al‐Warraky, GI El‐Azab, MAS Kohla, EE Abdelaal Apmis 123 (12), 1032-1039, 2015 | 28 | 2015 |
| Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis TA Salman, AM Edrees, HH El-Said, OL El-Abd, GI El-Azab European Journal of Gastroenterology & Hepatology 28 (7), 777-785, 2016 | 19 | 2016 |
| Treatment of hepatitis C virus infection in patients on maintenance hemodialysis: A single United Arab Emirates center experience A Giguere, A Anas, T Nasser, MH Hassan, U Ahmed, N Beejay, M Nouh, ... European journal of internal medicine 22 (6), 582-586, 2011 | 11 | 2011 |
| Acetaminophen plasma level after oral administration in liver cirrhotic patients suffering from schistosomal infection G El-Azab, MK Youssef, Y Higashi, T Murakami, N Yata International journal of clinical pharmacology and therapeutics 34 (7), 299-303, 1996 | 10 | 1996 |
| Mean platelet volume and mean platelet volume/platelet count ratio as markers for hepatocellular carcinoma in patients with chronic hepatitis C virus related cirrhosis K Metwaly, EA Sameea, G El-Azab, M Assem, M Abbasy, T Zakareya, ... Journal of Cancer Research and Experimental Oncology 8 (4), 33-40, 2016 | 8 | 2016 |
| Susceptibility patterns and virulence genotypes of Helicobacter pylori affecting eradication therapy outcomes among Egyptian patients with gastroduodenal diseases AM Asaad, G El-Azab, E Abdelsameea, O Elbahr, A Kamal, ... World Journal of Gastroenterology 29 (19), 2950, 2023 | 7 | 2023 |
| mRNA expression of interleukin-17 in viral hepatitis B and hepatocellular carcinoma patients A El-Hamid, K Ayman, ES Abou Elnour, GI El-Azab, HM El Sebaii, ... Menoufia Medical Journal 31 (3), 753-761, 2018 | 3 | 2018 |
| Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis O Mahmoud, W Abdel-Razek, G Abo-Raia, M Assem, G El-Azab International Journal Of Hepatology 2015, 2015 | 3 | 2015 |
| King’s fibrosis, fibrosis index, GPR, and ALBI score are useful models for liver fibrosis in chronic hepatitis B patients pre-and post-treatment A Alsebaey, R Badr, E Abdelsameea, MO Amer, MA Eljaky, G El-Azab, ... Hepatitis Monthly 19 (11), 2019 | 2 | 2019 |
| Serum Osteoprotegerin (OPG) as a Potential Biomarker for Disease Activity in Ulcerative Colitis AAA Ibrahim, GI El-Azab, NAA Allam, MM Hassouna, AM Edrees The Egyptian Journal of Hospital Medicine 91 (1), 4972-4977, 2023 | | 2023 |
| Prevalence and predictors of post-liver transplantation metabolic bone diseases M Elsabaawy, S Afify, G El-Azab, A Gomaa, N Omar, M Hashim, ... Clinical and Experimental Hepatology 7 (3), 286-292, 2021 | | 2021 |
| Gastroenterology and Hepatology Research MS Hashim, M Alsabaawy, S Afify, G El-Azab, N Omar Journal of GHR 9 (1), 3077-3081, 2020 | | 2020 |
| Validation of Hepatoma Arterial Embolization Prognostic (HAP) Score in Egyptian Patients with Hepatocellular Carcinoma M Kohla, G El-Azab, A Gomaa Gastroint Hepatol Dig Dis 2 (2), 1-5, 2019 | | 2019 |
| Urotensin II as a novel marker for portal hypertension and bleeding varices: an Egyptian survey K Metwally, MA Naguib, M Saeed, G El-Azab, M Assem Egyptian Liver Journal 5 (3), 54-59, 2015 | | 2015 |
| Research Article Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis M Omar, W Abdel-Razek, G Abo-Raia, M Assem, G El-Azab | | 2015 |
